[PDF] Top 20 Poster Session 8: Bladder Cancer

... Introduction: Urinary cytology and cystoscopy remain the gold standard for the detection and screening of bladder cancer (BC). In recent years multiple urinary biomarkers have been developed as non-invasive ... See full document

... Results: Of all patients, 99 (9.9%) had METS. The actuarial METS-free survival for all 1004 men was 81% (95% confidence interval [CI], 78- 84%) 20 years after surgery. Median time to METS after surgery was not reached ... See full document

... Methods: Three cohorts of men with PCa were enrolled: a control group consisting of patients on watchful waiting (Group A), those initiating ADT for advanced disease (Group B), and those undergoing adjuvant ADT in a ... See full document

... prostate cancer specific (21%) and physical and daily living ...the cancer is under control (37%), being treated as a person (34%), being informed about benefits and side effects of treatments (33%), and ... See full document

... from 8 to 81 yrs (Median 45) were performed, including nonfunctioning atrophic kidneys (7 cases) and kidney masses (9 cases, one of these cases was palliative due to known C-spine ... See full document

... Materials and Methods: We used the Québec Health Plan database to identify 12241 assessable men diagnosed with prostate cancer (PCa), who were treated between 1992 and 2000 with either bilateral orchiec- tomy ... See full document

... and cancer in remission; other baseline demographics were ...CKD, cancer in remission, and enema type with multivariable logistic regression, patients requiring admission were ... See full document

... Results: 485 patients received 561 kidney-only transplants. No patients were lost to followup. In Group 1 (n=261 transplants), the most common cause of end-stage kidney disease (ESKD) was congenital abnormality of the ... See full document

... Methods: The study focused on 1860 patients with cT1a kidney cancer treated with either LTA or EM between 2000 and 2009 in the Surveillance Epidemiology and End Results-Medicare database. Propensity-score match- ... See full document

... prostate cancer screening. The Urological community in Canada believes that abandoning screening will lead to an increase in the number of undetected clinically significant prostate cancers, and ultimately ... See full document

... Prostate cancer is the most common cancer in men in the UK and it is the second leading cause of cancer-related death in men with an estimated deaths in 2012 (Siegel R, Naishadham D, Jemal ...A. ... See full document

... Symptoms Score (IPSS), Quality of Life (QoL), peak flow rate (Qmax), residual urine (PVR) and prostatic specific antigen (PSA) at 1, 6, and 12 months and then annually. Perioperative and late adverse events were ... See full document

... Results: Of the 2925 renal and 2761 liver transplant recipients in our cohort, we identified eight patients following kidney transplant and three patients following liver transplant (n=11, 0.2%) diagnosed with ... See full document

... Results: 56 procedures on 54 patients (28 males, 26 females), mean age 10 (SD 5) and mean followup eight years. Bowel segments included: ileum in 49 (87.5%), ileum/cecum in two (3.6%), and one each (2.0%) of ileum/cecum, ... See full document

... Results: RAD001 was a very potent growth inhibitor for the nine screened bladder cancer cell lines. A G0/G1 as well as a G2 arrest was seen in the combined treatment compared to either treatment alone in ... See full document

... into bladder cancer, with concomitant local suppression of Treg-attracting ...with bladder cancer was analyzed by RT- PCR (Taqman) and ...activation bladder cancer explants ... See full document

... Introduction and Objective: It is widely accepted that nephron-sparing surgery (NSS) and radical nephrectomy (RN) achieve same cancer con- trol for T1a (<4cm) renal cell carcinoma. However, this affirmation ... See full document

... der cancer treated with intravesical BCG ...invasive bladder cancer (high grade or T1 tumours or multiple rapidly recurrent tumours refractory to intravesical chemotherapy) treated with transurethral ... See full document

... tion. Primary outcome is cost-effectiveness, with secondary outcomes of clinical efficacy, resection time, surgical team satisfaction, and safety. 60 patients will be randomized to achieve analysis of primary outcome. ... See full document

... the bladder and renal cell carcinoma were chosen as com- mon problems to be described in a case-based ...a bladder tumour, a cystectomy and ileal conduit, a neobladder diversion and a laparoscopic radical ... See full document